Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Dynamin 1 ELISA Kit (AC3798)
Cat.#: ASET-2387
Specifications
Description Human Dynamin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Dynamin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.044 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2328 Human EPHA10 ELISA Kit (AC3739) Quantitative inquiry ASET-2098 Human LCN1 ELISA Kit (AC3509) Quantitative inquiry ASET-2303 Human DCC ELISA Kit (AC3714) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry ASET-2132 Human Mitofusin 2 ELISA Kit (AC3543) Quantitative inquiry ASET-1836 Human MAdCAM1 ELISA Kit (AC3247) Quantitative inquiry ASET-1060 Mouse Homer1 ELISA Kit (AC2471) Quantitative inquiry ASET-1548 Human FLJ39155 ELISA Kit (AC2959) Quantitative inquiry ASET-2134 Human Myotrophin ELISA Kit (AC3545) Quantitative inquiry ASET-1245 Human CYP1B1 ELISA Kit (AC2656) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket